SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014 Report

[March 05, 2014]

Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014 Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/3m59wb/anaplastic_large) has announced the addition of the "Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014" report to their offering.

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014" provides data on the Anaplastic Large Cell Lymphoma (ALCL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL) .

It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of rials for the key drugs for treating Anaplastic Large Cell Lymphoma (ALCL).


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Key Topics Covered:

List of Tables

List of Figures

Introduction

Anaplastic Large Cell Lymphoma (ALCL)

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Clinical Trials by G7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Unaccomplished Trials of Anaplastic Large Cell Lymphoma (ALCL)

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials

Prominent Drugs

Five Key Clinical Profiles

Appendix

For more information visit http://www.researchandmarkets.com/research/3m59wb/anaplastic_large

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy